YOSHIO YAMAOKA to Amoxicillin
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Amoxicillin.
Connection Strength
1.787
-
Efficacy of Omeprazole, Tetracycline, and 4 Times Daily Dosing of Amoxicillin in Helicobacter pylori Eradication in Limited Resource Area in Bhutan: A Prospective Randomized Trial (BHUTAN Study). Asian Pac J Cancer Prev. 2020 Apr 01; 21(4):1109-1114.
Score: 0.696
-
Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates. Toxins (Basel). 2020 07 24; 12(8).
Score: 0.178
-
Population-based study of Helicobacter pylori infection and antibiotic resistance in Bhutan. Int J Infect Dis. 2020 Aug; 97:102-107.
Score: 0.176
-
Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Helicobacter pylori Infection in the Dominican Republic. Am J Trop Med Hyg. 2017 May; 96(5):1050-1059.
Score: 0.140
-
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations. PLoS One. 2016; 11(12):e0166199.
Score: 0.138
-
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. BMC Microbiol. 2016 11 04; 16(1):256.
Score: 0.138
-
Cut-off value of clarithromycin resistance in the treatment of Helicobacter pylori infection: how low is low? Gut. 2024 Jan 05; 73(2):374-375.
Score: 0.056
-
Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial). PLoS One. 2023; 18(11):e0294403.
Score: 0.056
-
Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2024 Jan; 9(1):56-67.
Score: 0.056
-
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial. Am J Gastroenterol. 2023 07 01; 118(7):1184-1195.
Score: 0.053
-
Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol. 2018 Jan; 33(1):37-56.
Score: 0.037
-
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017 10; 2(10):707-715.
Score: 0.036
-
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol. 2005 Nov; 100(11):2387-92.
Score: 0.016
-
Analysis of the 13C-urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta-13CO2 using laser spectroscopy. J Gastroenterol Hepatol. 1998 Jul; 13(7):732-7.
Score: 0.010